APPLICATION OF A CHAIN TERMINATION ASSAY FOR CHARACTERIZATION OF REVERSE-TRANSCRIPTASE FROM AZT-RESISTANT HIV ISOLATES

Citation
J. Lennerstrand et al., APPLICATION OF A CHAIN TERMINATION ASSAY FOR CHARACTERIZATION OF REVERSE-TRANSCRIPTASE FROM AZT-RESISTANT HIV ISOLATES, Antiviral chemistry & chemotherapy, 7(6), 1996, pp. 313-320
Citations number
32
Categorie Soggetti
Biology,"Pharmacology & Pharmacy
ISSN journal
09563202
Volume
7
Issue
6
Year of publication
1996
Pages
313 - 320
Database
ISI
SICI code
0956-3202(1996)7:6<313:AOACTA>2.0.ZU;2-R
Abstract
An enzymatic assay based on utilization of one primer/enzyme molecule was specifically designed for evaluation of the chain termination capa city of reverse transcriptase (RT) from HIV-1 isolates. In this assay system (CT assay) there was a 3.2-fold difference between the AZT-trip hosphate (AZT-TP) concentrations required to terminate 50% of the prim ers (TC50) for a highly resistant isolate, carrying the four common mu tations at positions 67, 70, 215, and 219; and two wild type isolates. Two of three other isolates with reduced sensitivity to AZT in cell c ulture exhibited intermediate values in CT assay, while one behaved as the wild type isolates. There was a correlation P = 0.05 (r = 0.86, n = 6) between the ED(50) values found in cell culture and the TC50 val ues found in CT assay. This relationship was not found in a similar as say system which measured competition between AZT-TP and 1 mu M tymidi ne triphosphate (TTP) at the enzymatic level. The sequence data of the current isolates gave some information concerning which mutations in the RT gene specifically affect the enzymatic properties measured in C T assay. Mutation only at amino acid 70 had no effect, but the TC50 va lues found increased with accumulation of the other common AZT resista nce mutations.